Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,107
Closed -$1.06M 472
2017
Q3
$1.06M Sell
9,107
-17,461
-66% -$2.21M 0.07% 285
2017
Q2
$3.35M Sell
26,568
-3,089
-10% -$393K 0.21% 140
2017
Q1
$3.96M Buy
29,657
+20,185
+213% +$2.57M 0.22% 139
2016
Q4
$950K Sell
9,472
-4,337
-31% -$423K 0.07% 288
2016
Q3
$1.3M Buy
13,809
+4,081
+42% +$344K 0.09% 235
2016
Q2
$778K Sell
9,728
-1,704
-15% -$132K 0.06% 300
2016
Q1
$828K Sell
11,432
-1,788
-14% -$133K 0.05% 347
2015
Q4
$1.43M Buy
+13,220
New +$1.47M 0.09% 241

Other funds holding INCY

GLG LLC's INCY Position: Q4 2017 in Review

GLG LLC sold out of Incyte (INCY) in Q4 2017, closing a stake of 9,107 shares — an estimated $1.06M sold.

GLG LLC first reported a position in INCY in Q4 2015 and held it in 8 quarters. The position peaked at $3.96M in Q1 2017. 503 funds tracked by Wall St. Rank hold INCY as of Q4 2017.

  • GLG LLC reported no remaining Incyte position as of Q4 2017 after selling out during the quarter.
  • GLG LLC sold 9,107 Incyte shares in Q4 2017, an estimated $1.06M.
  • GLG LLC first reported a position in Incyte in Q4 2015 and held it in 8 quarters.
  • GLG LLC's Incyte position peaked at $3.96M in Q1 2017.
  • 503 funds tracked by Wall St. Rank held Incyte as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.